Awakn Life Sciences’ Revenue up 534% in 2022, AUD Treatment Advances

April 30, 2023 · Green Market Report

The firm has made meaningful strides in its early clinical runway as it gears up for government-funded studies.

Toronto-based Awakn Life Sciences Corp. (OTC: AWKNF), a biotech company focused on addiction treatments, reported a heft 534% rise in annual revenue for the fiscal year ended Jan. 31, which they attribute to the strong performance of their clinics.

The company pulled in $1.5 million in annual revenue, a 534% increase year-on-year, with $471,813 in the fourth quarter, a 131% increase sequentially. Net loss for the year was $9.7 million, and improvement versus $16.5 million in 2021.

Awakn had around $550,866 in cash at the end of the period.

“Our clinics delivered strong revenue growth … and looking forward to the current fiscal year, we are targeting a further increase in revenue from our clinics and partnerships,” CEO Anthony Tennyson said in a statement.

Awakn’s main program, AWKN-P001, which aims to treat severe alcohol use disorder (AUD), is moving into phase III. The U.K. government will cover most of the trial costs, leaving Awakn to contribute only $1.25 million.

Additionally, the company is partnering with a European pharmaceutical firm to study the potential of repurposing (S)-ketamine for addiction treatment. Awakn is also working with Catalent on a study of MDMA, using Catalent’s proprietary oral disintegrating tablet technology, which could potentially shorten therapy sessions.

Recently, Awakn received an Innovation Passport – a licensing pathway for pre-clinical ventures – from the U.K. Medicines and Healthcare Products Regulatory Agency for its ketamine-assisted therapy for severe AUD. The company also signed a collaboration agreement with the University of Exeter for an upcoming phase III trial. (Full Story)

In categories:International State Bills
Next Post

Organigram takes Canadian government to court over cannabis lozenge dispute

Canadian marijuana operator Organigram Holdings is asking a federal court to quash a Health Canada decision that the company’s popular ingestible cannabis lozenges should be classified and regulated as edibles instead of extracts. The legal challenge could have broader implications for Canada’s…
Previous Post

Louisiana House Committee Kills Cannabis Legalization Bill

Louisiana lawmakers on Tuesday killed a bill to legalize adult-use cannabis in the state, the Lafayette Daily Advertiser reports. The House Criminal Justice Committee voted down the proposal 9-4.  The measure was opposed by the state’s sheriffs, district attorneys, and police chiefs…
Random Post

Kentucky Governor Pushes Lawmakers To Approve More Medical Marijuana Qualifying Conditions While Unveiling First Program Rules

The governor of Kentucky is urging lawmakers to significantly expand the state’s medical marijuana law by adding new qualifying conditions as the administration puts forward a series of initial proposed regulations to begin implementing the program. At a briefing on…
Random Post

Meet Wiz Khalifa at Trulieve Shops in Pittsburgh on Wiz Khalifa Day

Born in North Dakota, Wiz Khalifa ended up in PIttsburgh in 1996 at age nine when he mother moved the family there. He was known as Cameron Thomaz then. At 15, he changed his moniker to Khalifa and a few years later…
Random Post

Cannabis delivery, relaxed distribution rules get Henderson council’s approval

The Henderson City Council on Tuesday approved new rules to relax limitations on cannabis dispensaries within the city, including allowing delivery service. The new bill strikes a previous colocation requirement and limits the amount of cannabis sales facilities to no…
Random Post

NBA Players Can Now Smoke Weed Legally - Ending the Worst Kept Sports Secret, Ever.

According to a statement released by the National Basketball Players Association (NBPA), the NBA and the NBPA reached a deal over the weekend for the 2023-2024 season. The seven-year collective bargaining agreement specifies that NBA players will no longer be…